Another innovation from RB UK this time with its trusted bonjela brand. New* bonjela Junior is specially formulated to relieve pain associated with mouth ulcers which can be caused by the rubbing of orthodontic devices. It contains Lidocaine Hydrochloride, a mild anaesthetic which helps to numb associated pain or discomfort and cetylpyridinium chloride, an antiseptic which helps to fight infection. bonjela Junior is suitable for children from three months, is sugar free and has a pleasant banana flavour.
“33% of British children have crooked teeth and need orthodontic treatment to straighten them so managing mouth pain can be a huge problem area for parents with children aged 4-15 years. The new* bonjela Junior launch therefore represents a great solution for consumers and an exciting growth opportunity for retailers.” Mark Pearson RB Category Marketing Director
The bonjela Junior launch is being supported by a £1m promotional campaign involving television advertising (which broke in April), consumer PR and advertising, promotional activity with Emma’s Diary and Bounty and targeted information for dentists and pharmacists
New* bonjela Junior
• Sugar free
• Banana flavour
• Suitable for children under 16 (aged 3 months +)
• RRP: £3.49 (15g)
• Available from all good pharmacies and grocery stores
• Always read the label
• For the relief of pain from common mouth ulcers, denture irritation and infant teething pain
*New to Bonjela range
Reckitt Benckiser (RB) is a global consumer goods leader in health, hygiene and home. With a purpose of delivering innovative solutions for healthier lives and happier homes, RB is in the top 25 of companies listed on the London Stock Exchange. Today it is the global No 1 or No 2 in the majority of its fast-growing categories, driven by an exceptional rate of innovation. Its health, hygiene and home portfolio is led by 19 global Powerbrands including Nurofen, Strepsils Gaviscon, Mucinex, Durex, Scholl, Lysol, Dettol, Clearasil, Veet, Harpic, Bang, Mortein, Finish, Vanish, Woolite, Calgon, Air Wick, and French’s. RB has close to half of its revenues coming from it 2 emerging market Areas and just over half from its developed market Area. Over 70% of core revenues come from the health and hygiene categories of the portfolio.
RB people and its culture are at the heart of the company’s success. They have an intense drive for achievement and a desire to outperform wherever they focus, including in sustainability where the company has reduced its carbon footprint by 20% in 5 years and is now targeting to deliver a 1/3 reduction in water impact, 1/3 further reduction in carbon and to have 1/3 of its net revenue coming from more sustainable products by 2020. It is also the Save the Children charity’s largest FMCG global partner, with a new partnership vision to radically reduce the world’s second biggest killer of under-fives, diarrhoea.